195 related articles for article (PubMed ID: 25356981)
1. The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.
Batorsky R; Sergeev RA; Rouzine IM
PLoS Comput Biol; 2014 Oct; 10(10):e1003878. PubMed ID: 25356981
[TBL] [Abstract][Full Text] [Related]
2. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
3. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
5. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins.
Boutwell CL; Carlson JM; Lin TH; Seese A; Power KA; Peng J; Tang Y; Brumme ZL; Heckerman D; Schneidewind A; Allen TM
J Virol; 2013 Apr; 87(7):3952-65. PubMed ID: 23365420
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
[TBL] [Abstract][Full Text] [Related]
7. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
[TBL] [Abstract][Full Text] [Related]
8. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
9. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
Liu Y; McNevin J; Zhao H; Tebit DM; Troyer RM; McSweyn M; Ghosh AK; Shriner D; Arts EJ; McElrath MJ; Mullins JI
J Virol; 2007 Nov; 81(22):12179-88. PubMed ID: 17728222
[TBL] [Abstract][Full Text] [Related]
10. HIV evolution: CTL escape mutation and reversion after transmission.
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.
Borzooee F; Joris KD; Grant MD; Larijani M
Front Immunol; 2018; 9():3032. PubMed ID: 30687306
[TBL] [Abstract][Full Text] [Related]
12. Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.
Ganusov VV
Viruses; 2018 Feb; 10(3):. PubMed ID: 29495443
[TBL] [Abstract][Full Text] [Related]
13. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
Ganusov VV; Goonetilleke N; Liu MK; Ferrari G; Shaw GM; McMichael AJ; Borrow P; Korber BT; Perelson AS
J Virol; 2011 Oct; 85(20):10518-28. PubMed ID: 21835793
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics.
Yang Y; Ganusov VV
Front Immunol; 2018; 9():140. PubMed ID: 29472921
[TBL] [Abstract][Full Text] [Related]
15. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
Yang OO; Sarkis PT; Ali A; Harlow JD; Brander C; Kalams SA; Walker BD
J Exp Med; 2003 May; 197(10):1365-75. PubMed ID: 12743169
[TBL] [Abstract][Full Text] [Related]
16. [[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].
Shi Y; Wan Y; Xu J
Bing Du Xue Bao; 2015 May; 31(3):299-306. PubMed ID: 26470538
[TBL] [Abstract][Full Text] [Related]
17. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
18. Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
Mostowy R; Kouyos RD; Hoof I; Hinkley T; Haddad M; Whitcomb JM; Petropoulos CJ; Keşmir C; Bonhoeffer S
PLoS Comput Biol; 2012; 8(5):e1002525. PubMed ID: 22654656
[TBL] [Abstract][Full Text] [Related]
19. CD8
Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
[TBL] [Abstract][Full Text] [Related]
20. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.
Geels MJ; Cornelissen M; Schuitemaker H; Anderson K; Kwa D; Maas J; Dekker JT; Baan E; Zorgdrager F; van den Burg R; van Beelen M; Lukashov VV; Fu TM; Paxton WA; van der Hoek L; Dubey SA; Shiver JW; Goudsmit J
J Virol; 2003 Dec; 77(23):12430-40. PubMed ID: 14610167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
